Pseudomonas Aeruginosa Infection: Clinical Trials

3 trials for Pseudomonas Aeruginosa Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 3 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Unknown 1
Phase 12Completed 1, Unknown 1
Phase 31Completed 1

Follow Pseudomonas Aeruginosa Infection: new trials by email Literature Review of Pseudomonas Aeruginosa Infection trials Research Report on Pseudomonas Aeruginosa Infection

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG®
IMP, Placebo - Surgical Site Infection, Staphylococcus Aureus Infection
Phase 1 / Phase 2UnknownMB PHARMA s.r.o.522023-10-272024-03-19
Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers
TP-102 - Diabetic Foot Ulcer, Pseudomonas Aeruginosa Infection
Phase 1 / Phase 2CompletedTechnophage, SA202021-03-222022-10-04
Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43
IC43, Placebo - Pseudomonas Aeruginosa Infection
Phase 2 / Phase 3CompletedValneva Austria GmbH8032012-03-012016-03-31

Narrower conditions

Pseudomonas Infections (3)  ·  Staphylococcal Infections (2)  ·  Acinetobacter Infections (1)  ·  Bacterial Infections (1)  ·  Diabetic Foot (1)  ·  Surgical Wound Infection (1)

Broader conditions

Bacterial Infections and Mycoses (3)  ·  Gram-Negative Bacterial Infections (3)  ·  Infections (3)  ·  Bacterial Infections (2)  ·  Gram-Positive Bacterial Infections (2)  ·  Cardiovascular Diseases (1)  ·  Diabetes Complications (1)  ·  Diabetes Mellitus (1)  ·  Diabetic Angiopathies (1)  ·  Diabetic Neuropathies (1)  ·  Endocrine System Diseases (1)  ·  Foot Ulcer (1)  ·  Leg Ulcer (1)  ·  Moraxellaceae Infections (1)  ·  Pathologic Processes (1)

Interventions

Inosine Monophosphate (1)  ·  Sodium Chloride (1)

Sponsors

MB PHARMA s.r.o. (1)  ·  Technophage, SA (1)  ·  Valneva Austria GmbH (1)

Countries

Czechia (2)  ·  Austria (1)  ·  Belgium (1)  ·  Germany (1)  ·  Hungary (1)  ·  Israel (1)  ·  Spain (1)

Top investigators

Ran Nir-Paz, MD (1)  ·  Robert Staffa, prof. (1)  ·  Ronen Ben Ami, MD (1)  ·  Susanne Eder, Mag (1)

Results publications

PMID 32131866, PMID 39740667